Page 64 - Annual Report 2020

The Hormel Institute // JULY 1, 2019 – JUNE 30, 2020 August 15, 2019
Yan Liu, Ph.D.
Associate Professor
Department of Pediatrics
Indiana University School of Medicine
“Genetic and epigenetic control of pre-leukemic stem cells and leukemia stem cells”
August 22, 2019
David Langley, Ph.D.
Education Program Specialist Center for Education Innovation University of Minnesota
“Developing Memorable Presentations”
August 29, 2019
Amy H. Tang, Ph.D.
Professor of Cancer Biology
Leader of Pancreatic & Breast Cancer Research Eastern Virginia Medical School & Molecular
Cell Biology
Leroy T. Canoles Jr. Cancer Center
“Early Detection of Tumor Relapse, and Conquer Incurable Oncogenic K-RAS-Driven Malignant Cancer”
September 5, 2019
Ingunn Stromnes, Ph.D.
Assistant Professor
Department of Microbiology & Immunology University of Minnesota
“Mechanisms of immunotherapy response and resistance to pancreas cancer”
October 10, 2019
Pengbo Zhou, Ph.D.
Professor
Pathology & Laboratory Medicine
Weill Cornell Medicine
“Proteolytic control of DNA repair, reproduction and tumorigenesis”
October 31, 2019 Liguo Wang, Ph.D. Associate Professor Biomedical Informatics Mayo Clinic
“Prevalent Homozygous Deletions of Interferon and Defensin Genes in Human Cancers Associated with Immunotherapy Resistance”
November 21, 2019
Chris Pennell, Ph.D.
Associate Professor
Department of Laboratory Medicine & Pathology University of Minnesota
“Modeling CD19-Specific CAR T-cell Cancer Immunotherapy in vivo”
SEMINARS
January 9, 2020
Paola Vermeer, Ph.D.
Assistant Scientist
Tumor Intervention and Disease Progression Sanford Research
“Exosome-mediated tumor innervation leads to clinically more aggressive disease”
January 30, 2020
Jeffrey L. Salisbury, Ph.D.
Professor
Biochemistry & Molecular Biology
Mayo Clinic
“3D Electron Microscopy for Understanding Tissue Architecture in Normal and Disease Processes”
February 6, 2020
Ruping Sun, Ph.D.
Assistant Professor
Department of Laboratory Medicine & Pathology University of Minnesota
“Connecting ITH to the time and space of tumor dynamics”
February 27, 2020
Kevin Myers, Ph.D.
Senior Vice President of Research and Development Hormel Foods
“Alternative careers for scientists in industry”
April 9, 2020
Martina Bazzaro, Ph.D.
Associate Professor
Department of Obstetrics, Gynecology & Women’s Health University of Minnesota
“Targeting mitochondrial metabolism for the treatment of Ovarian Clear Cell Carcinoma”
April 16, 2020
Geeta Mehta, Ph.D.
Associate Professor
Materials Science and Engineering
Macromolecular Science and Engineering
Biomedical Engineering
University of Michigan
“Patient-derived 3D ‘Tumor as Organ’ Models for Exploration of Cancer Stem Cell Regulation, Chemoresistance, and Heterogeneity”
April 23, 2020
Robert Clarke, Ph.D., D.Sc.
Professor
Department of Oncology
Co-Director, Breast Cancer Program
Georgetown University
“Understanding endocrine resistance in breast cancer: a systems biology perspective”
April 30, 2020
Enis Kostallari, Ph.D.
Associate Consultant
Hepatic Vascular Cellular Signaling
Mayo Clinic
“Hepatic stellate cell autophagy inhibits extracellular vesicle release to attenuate liver fibrosis”
May 7, 2020
Fabrice Lucien, Ph.D.
Associate Consultant
Parkinson’s Disease and Synucleinopathies Research Mayo Clinic
“Extracellular Vesicles: Exploiting “The Message in the Bottle” for the Management of Human Cancers”
May 28, 2020
Yang Yang, Ph.D.
Assistant Professor
Obstetrics, Gynecology & Reproductive Sciences Yale School of Medicine
“From the first mutation to advanced ovarian cancer”
June 4, 2020
Hilary Kenny, Ph.D.
Research Assistant Professor
Department of Obstetrics and Gynecology University of Chicago
“Modeling the Ovarian Cancer Microenvironment”
June 11, 2020
Ayesha Alvero, M.D., M.Sc.
Professor
Department of Obstetrics and Gynecology
Wayne State University
“Novel targetable pathways to curtail recurrence, lessons learned from 15+ years of drug discovery research”